EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Moesin controls cell–cell fusion and osteoclast function

Ophélie Dufrançais iD, Marianna Plozza iD, Marie Juzans iD, Arnaud Métais iD, Sarah C Monard iD, Pierre-Jean Bordignon iD, Perrine Verdys iD, Thibaut Sanchez iD, Martin Bergert iD, Julia Halper iD, Christopher J Panebianco iD, Rémi Mascarau iD und 15 weitere

Journal of Cell Biology · 2025

DOI: 10.1083/jcb.202409169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cell Biology, 2025. Verfasst von Ophélie Dufrançais und 26 weiteren Autor:innen. Beteiligte Einrichtung: Institut de Pharmacologie et Biologie Structurale (IPBS), Université de Toulouse, Centre National de la Recherche Scientifique, Université Toulouse I…. Hauptthemen laut MEDLINE: Osteoclasts, Microfilament Proteins. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Université Toulouse III - Paul Sabatier (UT3), Centre National de la Recherche Scientifique, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cell–cell fusion is an evolutionarily conserved process that is essential for many functions, including the formation of bone-resorbing multinucleated osteoclasts. Osteoclast multinucleation involves dynamic interactions between the actin cytoskeleton and the plasma membrane that are still poorly characterized. We found that moesin, a cytoskeletal linker protein member of the Ezrin, radixin, and moesin (ERM) protein family, plays a critical role in both osteoclast fusion and function. Moesin inhibition favors osteoclast multinucleation as well as HIV-1- and inflammation-induced cell fusion. Accordingly, moesin depletion decreases membrane-to-cortex attachment and enhances the formation of tunneling nanotubes, F-actin–based intercellular bridges triggering cell–cell fusion. In addition, moesin regulates the formation of the sealing zone, a key structure determining osteoclast bone resorption area, and thus controls bone degradation via a β3-integrin/RhoA/SLK pathway. Finally, moesin-deficient mice have reduced bone density and increased osteoclast abundance and activity. These findings provide a better understanding of cell–cell fusion and osteoclast biology, opening new opportunities to specifically target osteoclasts in bone disease therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoclastsMicrofilament ProteinsAnimalsCell FusionMiceBone ResorptionHumansMice, Inbred C57BLActinsActin CytoskeletonrhoA GTP-Binding ProteinMice, KnockoutSignal Transduction

Substanzen

moesinMicrofilament ProteinsActinsrhoA GTP-Binding Protein

Autor:innen und Institutionen

  • Institut de Pharmacologie et Biologie Structurale (IPBS), Université de Toulouse, Centre National de la Recherche Scientifique, Université Toulouse III - Paul Sabatier (UT3) , Toulouse, France.
  • Children's Hospital of Philadelphia Research Institute, University of Pennsylvania Perelman School of Medicine , Philadelphia, PA, USA.
  • Cell Biology and Biophysics Unit, European Molecular Biology Laboratory , Heidelberg, Germany.
  • Université Côte d'Azur, CNRS, LP2M , Nice, France.
  • Department of Orthopaedic Surgery and Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA.
  • Centre de Recherches en Cancérologie de Toulouse, Inserm UMR1037 and Institut Universitaire du Cancer de Toulouse - Oncopôle , Toulouse, France.

ORCID-Profile: Ophélie Dufrançais, Marianna Plozza, Marie Juzans, Arnaud Métais, Sarah C Monard, Pierre-Jean Bordignon, Perrine Verdys, Thibaut Sanchez, Martin Bergert, Julia Halper, Christopher J Panebianco, Rémi Mascarau, Rémi Gence, Gaëlle Arnaud, Myriam Ben Neji, Isabelle Maridonneau-Parini, Véronique Le Cabec, Joel D Boerckel, Nathan J Pavlos, Alba Diz-Muñoz, Frédéric Lagarrigue, Claudine Blin-Wakkach, Sébastien Carréno, Renaud Poincloux, Janis K Burkhardt, Brigitte Raynaud-Messina, Christel Vérollet

Förderung

  • Université Toulouse III - Paul Sabatier (UT3)
  • Centre National de la Recherche Scientifique
  • NIH HHS
  • French National Research Agency
  • National Health & Medical Research Council of Australia
  • NIGMS NIH HHS
  • NIAID NIH HHS
  • Fondation pour la Recherche Médicale

Zitieren

APA

Dufrançais, O., Plozza, M., Juzans, M., Métais, A., Monard, S. C., Bordignon, P. J., Verdys, P., Sanchez, T., Bergert, M., Halper, J., Panebianco, C. J., Mascarau, R., Gence, R., Arnaud, G., Ben Neji, M., Maridonneau-Parini, I., Le Cabec, V., Boerckel, J. D., Pavlos, N. J., …, & Vérollet, C. (2025). Moesin controls cell–cell fusion and osteoclast function. Journal of Cell Biology. https://doi.org/10.1083/jcb.202409169

Vancouver

Dufrançais O, Plozza M, Juzans M, Métais A, Monard SC, Bordignon PJ, et al. Moesin controls cell–cell fusion and osteoclast function. Journal of Cell Biology. 2025. doi:10.1083/jcb.202409169

BibTeX
@article{Dufranais2025,
  author = {Dufrançais, Ophélie and Plozza, Marianna and Juzans, Marie and Métais, Arnaud and Monard, Sarah C and Bordignon, Pierre-Jean and Verdys, Perrine and Sanchez, Thibaut and Bergert, Martin and Halper, Julia and Panebianco, Christopher J and Mascarau, Rémi and Gence, Rémi and Arnaud, Gaëlle and Ben Neji, Myriam and Maridonneau-Parini, Isabelle and Le Cabec, Véronique and Boerckel, Joel D and Pavlos, Nathan J and Diz-Muñoz, Alba and Lagarrigue, Frédéric and Blin-Wakkach, Claudine and Carréno, Sébastien and Poincloux, Renaud and Burkhardt, Janis K and Raynaud-Messina, Brigitte and Vérollet, Christel},
  title = {Moesin controls cell–cell fusion and osteoclast function},
  journal = {Journal of Cell Biology},
  year = {2025},
  doi = {10.1083/jcb.202409169}
}
Kostenlos starten →